An MDL is created when there are a number of lawsuits with common questions of fact. In this case, multiple Mirena® intrauterine device (IUD) lawsuits allege that the IUD is defective and can spontaneously migrate outside of the uterus, causing injuries. The petition (In Re: Mirena IUD Product Liability Litigation, Case No. 1:12-CV-2780) seeks to transfer the cases to the U.S. District Court for the Northern District of Ohio, Eastern Division before the Honorable Patricia A. Gaughan. By centralizing the lawsuits in one court before one judge, pre-trial proceedings will be more efficient and duplicate findings will be avoided.
Mirena®, an intrauterine contraceptive device (IUD), received U.S. Food and Drug Administration (FDA) approval in 2000. The device must be placed inside the uterus by a healthcare professional. It slowly releases the hormone levonorgestrel while implanted to prevent pregnancy and can remain in the body for up to five years. The FDA reports that the most serious adverse events associated with the Mirena® in its time on the market include: perforation of the uterine wall, ectopic pregnancy, intrauterine pregnancy, embedment of the device in the uterine wall, group A streptococcal sepsis, and pelvic inflammatory disease (PID).
Surgery is typically required to remove the Mirena® IUD when the device perforates the uterus and migrates outside the uterus, and this can lead to a number of injuries, including adhesions, infections, and organ damage, according to the American Association for Justice (AAJ) – Mirena® IUD Litigation Group. Matthew J. McCauley, Senior Litigation Counsel at Parker Waichman LLP, co-chairs the Group.